Rebecca Brown

发表

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

S. Rowland-Jones, D. Montefiori, J. Theiler, 2020, Cell.

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

Joshua B. Singer, Darren L. Smith, Shane A. McCarthy, 2021, The Lancet Infectious Diseases.

mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals

P. Klenerman, E. Barnes, M. Carroll, 2022, Frontiers in Immunology.

T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study

P. Klenerman, S. Rowland-Jones, M. Haniffa, 2021, The Lancet Microbe.

Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant

Graham W. Taylor, Joshua B. Singer, Darren L. Smith, 2021, Science.

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

D. A. Jackson, Graham W. Taylor, William L. Hamilton, 2020, Cell.

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Graham W. Taylor, Joshua B. Singer, Scott M Elliott, 2021, Nature.

SARS-CoV-2 evolution during treatment of chronic infection

Graham W. Taylor, William L. Hamilton, Joshua B. Singer, 2021, Nature.

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Rosalind J Wright, P. Klenerman, S. Rowland-Jones, 2021, Cell.

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

William T. Harvey, Graham W. Taylor, William L. Hamilton, 2021, Cell Reports.

Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust.

S. Rowland-Jones, A. Kucharski, D. James, 2022, Wellcome open research.

Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust

S. Rowland-Jones, A. Kucharski, D. James, 2021, Wellcome open research.

Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust

S. Rowland-Jones, A. Kucharski, D. James, 2021, medRxiv.

Title: Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust.

A. Kucharski, D. James, J. Sayers, 2021 .

Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission

Graham W. Taylor, Scott M Elliott, Jaime M. Tovar-Corona, 2022, Nature Communications.

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

D. Weissman, Laura L. Sutherland, B. Haynes, 2020, Cell Host & Microbe.

The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

J. Knight, S. Rowland-Jones, G. Ogg, 2021, bioRxiv.

SARS-CoV-2 evolution during treatment of chronic infection

Graham W. Taylor, William L. Hamilton, Joshua B. Singer, 2021, Nature.

Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data

S. Mallal, A. Kohl, S. Gaudieri, 2021, Genome research.

Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens

P. Klenerman, S. Rowland-Jones, G. Screaton, 2023, Med.

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Graham W. Taylor, William L. Hamilton, Joshua B. Singer, 2021, Nature.

Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine

P. Klenerman, S. Rowland-Jones, G. Screaton, 2021, SSRN Electronic Journal.

T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study

P. Klenerman, E. Barnes, S. Hopkins, 2021, SSRN Electronic Journal.

Characterising within-hospital SARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves

Carl A. B. Pearson, A. Cori, T. Jombart, 2022, Nature Communications.

Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy

J. Sayers, T. D. de Silva, Rebecca Brown, 2023, iScience.

periscope: sub-genomic RNA identification in SARS-CoV-2 Genomic Sequencing Data

S. Mallal, A. Kohl, S. Gaudieri, 2020, bioRxiv.

Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2

S. Rowland-Jones, A. Angyal, Rebecca Brown, 2020 .

Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy

J. Sayers, T. D. de Silva, Rebecca Brown, 2023, iScience.

Publisher Correction: Characterising within-hospital SARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves

Carl A. B. Pearson, A. Cori, T. Jombart, 2022, Nature Communications.

of Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity

D. A. Jackson, Graham W. Taylor, William L. Hamilton, 2021 .

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

Joshua B. Singer, David A. Drew, Scott M Elliott, 2021, The Lancet. Public health.